Market Place
Sourcing Support
Astrazeneca Begins Trading On The New York Stock Exchange
03 Feb 2026 //
BUSINESSWIRE
Daiichi Stops Internal Development Of Next-Wave ADC
02 Feb 2026 //
FIERCE BIOTECH
AstraZeneca returns to China`s CSPC for $18.5B obesity dea
31 Jan 2026 //
PRESS RELEASE
Astrazeneca Vows $15B China Investment To Boost R&D Capabilities
30 Jan 2026 //
FIERCE BIOTECH
Multiply Labs Partners to Automate Cell Therapy Manufacturing
27 Jan 2026 //
BUSINESSWIRE
AstraZeneca keeps UK Research Site on Pause, But Options Open
27 Jan 2026 //
FIERCE BIOTECH
Daiichi Sankyo Navigates Complexity Of Success
26 Jan 2026 //
FIERCE PHARMA
AstraZeneca keeps UK research site on pause, but options open
26 Jan 2026 //
FIERCE BIOTECH
AstraZeneca to delist from Nasdaq, join NYSE in February
20 Jan 2026 //
REUTERS
ENHERTU + Pertuzumab EU Filing Validated for HER2+ Breast Cancer
19 Jan 2026 //
BUSINESSWIRE
ENHERTU Plus Pertuzumab EU Type II Variation Validated
19 Jan 2026 //
BUSINESSWIRE
AstraZeneca Acquires China Rights to GPC3 Armored CAR-T Therapy
18 Jan 2026 //
PR NEWSWIRE
FDA Proposes Febrile Seizure Warnings on Flu Shot Labels
17 Jan 2026 //
FIERCE PHARMA
AZ`s $80B Revenue Target `Very Much Within Reach,` CFO Says
14 Jan 2026 //
FIERCE PHARMA
Barnardo & Astrazeneca Partner On Young Health Programme For UK
13 Jan 2026 //
PHARMIWEB
DATROWAY Ph 3 TROPION-Lung17 Trial Initiated in NSCLC Cancer
13 Jan 2026 //
BUSINESSWIRE
AstraZeneca to acquire Modella AI to Speed Oncology Drug Research
13 Jan 2026 //
PRESS RELEASE
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Astrazeneca Appoints Laura Colon As New President Of Spain
10 Jan 2026 //
INDPHARMAPOST
Rick R. Suarez Appointed US President Of US Biopharma Unit
09 Jan 2026 //
PHARMIWEB
Bostongene, Astrazeneca Partner To Advance Oncology Development
06 Jan 2026 //
BUSINESSWIRE
AZ Touts Phase 3 Lupus Win For Subcutaneous Saphnelo
06 Jan 2026 //
FIERCE PHARMA
Astrazeneca Elevates Vikram Chand As SVP, Head Of R&D For Japan
04 Jan 2026 //
INDPHARMAPOST
Astrazeneca`s Ph. 3 Cancer Fail Is Latest Blow To ATR Inhibitors
24 Dec 2025 //
FIERCE BIOTECH
FDA Grants ENHERTU BTD for HER2+ Early Breast Cancer
22 Dec 2025 //
BUSINESSWIRE
FDA OKs ENHERTU Breakthrough Designation for HER2+ Breast Cancer
22 Dec 2025 //
BUSINESSWIRE
Jacobio Enter Global Exclusive License Agreement with AstraZeneca
21 Dec 2025 //
PR NEWSWIRE
AZ To Pull Bleeding Reversal Agent After FDA Flags Risk Imbalance
19 Dec 2025 //
FIERCE PHARMA
Niowave Expands Supply Deal With Astrazeneca For Actinium-225
18 Dec 2025 //
PR NEWSWIRE
EU Validates DATROWAY for First-Line Metastatic Treatment
18 Dec 2025 //
BUSINESSWIRE
Astrazeneca India Granted CDSCO Approval For Datopotamab
18 Dec 2025 //
INDPHARMAPOST
Compugen Monetizes AstraZeneca Rilvegostomig Royalties Up to $90M
17 Dec 2025 //
PR NEWSWIRE
GSK`s Saphnelo EU Approved For Self-Administered Lupus Pen
16 Dec 2025 //
PHARMIWEB
FDA Approves Roche`s ENHERTU for HER2+ Metastatic Breast Cancer
16 Dec 2025 //
PR NEWSWIRE
FDA Approves AZ/Daiichi`s Enhertu in 1st-Line Breast Cancer
15 Dec 2025 //
BUSINESSWIRE
FDA Launches Probe Into Safety Of Approved Anti-RSV Antibodies
10 Dec 2025 //
BIOSPACE
Therapy Eases Side Effects for 75% of Black Breast Cancer
10 Dec 2025 //
BUSINESSWIRE
DESTINY-Ovarian01—ENHERTU Phase 3 Begins for HER2+Ovarian Cancer
09 Dec 2025 //
BUSINESSWIRE
Merck, Sanofi, AZ Shots For RSV Now Under Scrutiny By FDA
09 Dec 2025 //
FIERCE PHARMA
Pillar Bio, Astrazeneca Expand Liquid Biopsy Access In China
08 Dec 2025 //
PR NEWSWIRE
Neurimmune Expands Collaboration With Astrazeneca On NI009
04 Dec 2025 //
PR NEWSWIRE
AstraZeneca Picks Salesforce Agentforce for Life Sciences
04 Dec 2025 //
BUSINESSWIRE
AstraZeneca`s Record ASH Presence Advances Hematology
04 Dec 2025 //
BUSINESSWIRE
U.S. FDA Accepts Baxdrostat NDA for Priority Review
02 Dec 2025 //
BUSINESSWIRE
Az`s Imfinzi Bags Perioperative Nod In Early-Stage Stomach Cancer
25 Nov 2025 //
FIERCE PHARMA
Harbour Biomed, Astrazeneca Collaborate On Oncology
23 Nov 2025 //
PR NEWSWIRE
AstraZeneca plans $2 Billion Manufacturing Investment
21 Nov 2025 //
PRESS RELEASE
Astrazeneca Strengthens COPD Treatment Pathways
19 Nov 2025 //
EXPRESSPHARMA
Astrazeneca, Sun Pharma Partner To Expand Hyperkalemia Treatment
17 Nov 2025 //
EXPRESSPHARMA
Astrazeneca Lands OPDP Untitled Letter Over Farxiga TV Ad
17 Nov 2025 //
RAPS
Baxdrostat Cuts 24-Hr Systolic BP By 14 mmHg In Bax24 Ph3 Trial
09 Nov 2025 //
BUSINESSWIRE
Regeneron, AZ Regulatory Plans Bolstered By Ph. 3 Wins
07 Nov 2025 //
BUSINESSWIRE
Astrazeneca Expands Obesity Pipeline Focusing On Medical Aspects
06 Nov 2025 //
BIOSPACE
Astrazeneca`s 9M And Q3 2025 Financial Results
06 Nov 2025 //
BUSINESSWIRE
Astrazeneca Adds $136M Investment To Chinese Inhalants Facility
06 Nov 2025 //
FIERCE PHARMA
Breakthrough Properties Finishes Leasing One Helix To Astrazeneca
04 Nov 2025 //
PR NEWSWIRE
EU Okays Alexion’s Koselugo For Adults With Neurofibromatosis
31 Oct 2025 //
INDPHARMAPOST
Destiny-Lung06 Trial Begins: Enhertu Phase 3 For 1St-Line HER2
30 Oct 2025 //
BUSINESSWIRE
Takeda Drops Az-Partnered Neurological Program After Ph. 2 Fail
30 Oct 2025 //
FIERCE BIOTECH
Biogen Seeks To Stand Out In Lupus With New Anti-CD40L Data
28 Oct 2025 //
BIOSPACE
